Literature DB >> 15338333

Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.

X-Q Li1, J-W Zhang, Z-X Zhang, D Chen, Q-M Qu.   

Abstract

Interleukin-1 (IL-1) has been implicated as a key cytokine in Alzheimer's disease (AD) pathogenesis. IL-1 gene polymorphisms, especially IL-1A C((-)889)T polymorphism, have been suggested to be associated with AD risk and onset age. To determine if IL-1 polymorphisms are genetic risk factors for developing AD in Chinese Mainland population, we analyzed IL-1A ((-)889), IL-1B ((-)511) and IL-1RN variable number of tandem repeat (VNTR) polymorphisms in a sample of 145 sporadic AD patients and 181 healthy controls. Our data revealed that the three polymorphisms in IL-1 gene cluster might not play a key role in AD pathogenesis in Chinese Mainland Han population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338333     DOI: 10.1007/s00702-004-0148-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  10 in total

Review 1.  Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation.

Authors:  Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies.

Authors:  Xue Qin; Qiliu Peng; Zhiyu Zeng; Zhiping Chen; Liwen Lin; Yan Deng; Xiamei Huang; Juanjuan Xu; Huiling Wu; Shan Huang; Shan Li; Jinmin Zhao
Journal:  J Neurol       Date:  2012-01-11       Impact factor: 4.849

3.  Association between interleukin-1α C(-889)T polymorphism and Alzheimer's disease: a meta-analysis including 12,817 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Lu Guo; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing Xiang; Jing-Cheng Li
Journal:  J Neural Transm (Vienna)       Date:  2012-07-28       Impact factor: 3.575

4.  Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis.

Authors:  Hai Yuan; Qing Xia; Pingping Ge; Shaowei Wu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

5.  Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease.

Authors:  Ji-Liang Hu; Gang Li; De-Xiang Zhou; Yu-Xi Zou; Zhi-Shan Zhu; Ru-Xiang Xu; Xiao-Dan Jiang; Yan-Jun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-08-15       Impact factor: 5.046

6.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

7.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

8.  Genetic effect of interleukin-1 beta (C-511T) polymorphism on the structural covariance network and white matter integrity in Alzheimer's disease.

Authors:  Chi-Wei Huang; Shih-Wei Hsu; Shih-Jen Tsai; Nai-Ching Chen; Mu-En Liu; Chen-Chang Lee; Shu-Hua Huang; Weng-Neng Chang; Ya-Ting Chang; Wan-Chen Tsai; Chiung-Chih Chang
Journal:  J Neuroinflammation       Date:  2017-01-18       Impact factor: 8.322

9.  Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.

Authors:  Greta Pšemeneckienė; Kęstutis Petrikonis; And Daiva Rastenytė
Journal:  Medicina (Kaunas)       Date:  2019-10-15       Impact factor: 2.430

10.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.